{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:21:07Z","timestamp":1763558467503,"version":"3.45.0"},"reference-count":26,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Heart failure (HF) is a complex pathology, being a consequence of multiple and intricated pathophysiological mechanisms that seldom occur on their own in the absence of other pathologies In the majority of cases, HF represents the outcome of other associated pathologies (coronary artery disease, systemic hypertension, diabetes mellitus, liver disease, chronic kidney disease, neurologic disorders) that coexist with HF, creating a vicious circle in which each disease is aggravated by the others [...]<\/jats:p>","DOI":"10.3390\/jcm14228122","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:55:31Z","timestamp":1763556931000},"page":"8122","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Management of Patients with Heart Failure\u20142nd Edition"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-741X","authenticated-orcid":false,"given":"Cristina","family":"Tudoran","sequence":"first","affiliation":[{"name":"Department VII, Internal Medicine II, Discipline of Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"Center of Molecular Research in Nephrology and Vascular Disease, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"County Emergency Hospital \u201cPius Brinzeu\u201d, L. Rebreanu, Nr. 156, 300723 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kim, B.S., Park, J.J., Choi, J.-H., Kwon, C.H., Kim, S.H., Jeon, K., Chung, Y., Kim, H.Y., and Kim, H.-J. (2025). High-Sensitivity Cardiac Troponin as a Predictor of Atrial Fibrillation Detected After Stroke: Implications for Subsequent Cerebrocardiovascular Events. J. Clin. Med., 14.","DOI":"10.3390\/jcm14217542"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Militaru, M., Lighezan, D.F., Tudoran, C., and Militaru, A.G. (2024). Connections Between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030672"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.37358\/RC.18.1.6084","article-title":"Is There a Sex Difference of Cardiovascular Risk Factors in Patients with Acute Myocardial Infarction?","volume":"69","author":"Anghel","year":"2018","journal-title":"Rev. Chim."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ejhf.2417","article-title":"A Population-Based Study of 92 Clinically Recognized Risk Factors for Heart Failure: Co-Occurrence, Prognosis and Preventive Potential","volume":"24","author":"Banerjee","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.37358\/MP.19.1.5118","article-title":"Aspects of Heart Failure in Patients with Ischemic Heart Disease After Percutaneous Coronary Revascularization with Polymer-Coated Drug-Eluting Stents Versus Bare-Metal Stents","volume":"56","author":"Tudoran","year":"2019","journal-title":"Mat. Plast."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ulambayar, B., and Nagy, A.C. (2025). Artificial Sweeteners and Cardiovascular Risk in Hungary: Beyond Traditional Risk Factors. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134641"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100911","DOI":"10.1016\/j.jhepr.2023.100911","article-title":"Cardiomyopathy in Cirrhosis: From Pathophysiology to Clinical Care","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lupu, D., Sc\u00e2rneciu, C.C., \u021a\u00een\u021b, D., and Tudoran, C. (2025). Cirrhotic Cardiomyopathy: Bridging Hepatic and Cardiac Pathophysiology in the Modern Era. J. Clin. Med., 14.","DOI":"10.3390\/jcm14175993"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"V\u00eertosu, D.-M., Munteanu Dragomir, A., Cri\u0219an, S., Luca, S., P\u0103tru, O., B\u0103ghin\u0103, R.-M., Laz\u0103r, M.-A., Cozlac, A.-R., Iurciuc, S., and Luca, C.-T. (2025). Prevalence of Healthcare-Associated Infections in Patients with Cardiovascular Diseases: A Literature Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144941"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Oswald, T., Malomo, S., Alway, T., Hadjivassilev, S., Coombs, S., Ellery, S., Lee, J., Phillips, C., Philips, B., and James, R. (2025). Guideline-Directed Medical Therapy in Sepsis Survivors with Left Ventricular Systolic Dysfunction: An Observational Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14093253"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tudoran, C., Tudoran, M., Lazureanu, V.E., Marinescu, A.R., Cut, T.G., Oancea, C., Pescariu, S.A., and Pop, G.N. (2021). Factors Influencing the Evolution of Pulmonary Hypertension in Previously Healthy Subjects Recovering from a SARS-CoV-2 Infection. J. Clin. Med., 10.","DOI":"10.37247\/PAMED4ED.4.22.4"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-023-01887-4","article-title":"Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction","volume":"83","author":"Patel","year":"2023","journal-title":"Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Anghel, L., Sasc\u0103u, R., Zota, I.M., and St\u0103tescu, C. (2021). Well-known and novel serum biomarkers for risk stratification of patients with non-ischemic dilated cardiomyopathy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115688"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ohnewein, B., Shomanova, Z., Jirak, P., Paar, V., Topf, A., Pylypenko, L., Sch\u00e4binger, M., Volg, F., Hoppe, U.C., and Pistulli, R. (2025). Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14165668"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Iyngkaran, P., Fazli, F., Nguyen, H., Patel, T., and Hanna, F. (2025). Historical Gaps in the Integration of Patient-Centric Self-Management Components in HFrEF Interventions: An Umbrella Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082832"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ramos-Polo, R., Ras-Jim\u00e9nez, M.d.M., Basalo Carbajales, M.d.C., Jovells-Vaqu\u00e9, S., Garcia-Pinilla, J.M., Cobo-Marcos, M., de Juan-Bagud\u00e1, J., Fonseca, C., Francesch Manzano, J., and Cosa, A.E. (2025). Myocardial Performance Improvement After Iron Replacement in Heart Failure Patients: The IRON-PATH II Echo-Substudy. J. Clin. Med., 14.","DOI":"10.1101\/2025.02.19.25322580"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bodea, O., Boia, E.R., Craciun, L.M., Valcovici, M.D., Motofelea, A.C., Munteanu, A.M., Streian, C.G., Pop, G.N., and Dragan, S.R. (2025). Effect of Coenzyme Q10 Supplementation on Cardiac Function and Quality of Life in Patients with Heart Failure: A Randomized Controlled Trial. J. Clin. Med., 14.","DOI":"10.3390\/jcm14113675"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.36628\/ijhf.2024.0041","article-title":"Predictors and Trends of 30-Day Readmissions in Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction: Insight from the National Readmission Database","volume":"7","author":"DeAngelo","year":"2025","journal-title":"Int. J. Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Baris, R.O., and Tabit, C.E. (2025). Heart Failure Readmission Prevention Strategies\u2014A Comparative Review of Medications, Devices, and Other Interventions. J. Clin. Med., 14.","DOI":"10.3390\/jcm14165894"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Scar\u00e0, A., Palam\u00e0, Z., Robles, A.G., Dei, L.-L., Borrelli, A., Zanin, F., Pignalosa, L., Romano, S., and Sciarra, L. (2024). Non-Pharmacological Treatment of Heart Failure\u2014From Physical Activity to Electrical Therapies: A Literature Review. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11040122"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Stoicescu, C., Vacarescu, C., and Cozma, D. (2025). HDL Function Versus Small Dense LDL: Cardiovascular Benefits and Implications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144945"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.124.070105","article-title":"Cardiac Resynchronization Therapy: New Perspectives","volume":"150","author":"Daubert","year":"2024","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Faur-Grigori, A.A., V\u0103c\u0103rescu, C., Nistor, S., Luca, S.A., Liviu, C., Cri\u0219an, S., Luca, C.-T., V\u0103t\u0103\u0219escu, R.-G., and Cozma, D. (2025). Refining Patient Selection Criteria for LV-Only Fusion Pacing in Cardiac Resynchronization Therapy: A Systematic Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144853"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"P\u0103tru, O., Luca, S., Cozma, D., V\u0103c\u0103rescu, C., Cri\u0219an, S., Valcovici, M.D., V\u00eertosu, M., Zus, A.S., Luca, C.T., and Dr\u0103gan, S.R. (2025). The Role of ARNI in Enhancing Outcomes of Cardiac Resynchronization Therapy: A Comprehensive Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082743"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/8122\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:17:40Z","timestamp":1763558260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/8122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":26,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14228122"],"URL":"https:\/\/doi.org\/10.3390\/jcm14228122","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}